Population-level distribution and putative immunogenicity of cancer neoepitopes
M. A. Wood, M. Paralkar, M. P. Paralkar, A. Nguyen, A. J. Struck, K. Ellrott, A. Margolin, A. Nellore, R. F. Thompson
The paper introduces four metrics to prioritize neoepitopes based on peptide novelty and evaluates their immunogenicity using TCGA and melanoma patient data.
bioRxiv · Apr 4, 2018Cancer Biology